The Immunological Functions of Muramyl Dipeptide Compound Adjuvant on Humoral, Cellular-Mediated and Mucosal Immune Responses to PEDV Inactivated Vaccine in Mice

摘要

Background: The muramyl dipeptide compound adjuvant, CVC1303, was one new resigned adjuvant to PEDV inactivated vaccine. Exploring the effects of CVC1303 on the immune induction to PEDV vaccine was of vital importance to the clinical application.